Sunday July 23rd 2017

[Comment] New evidence for teriflunomide in multiple sclerosis

Multiple sclerosis is an inflammatory demyelinating disorder of the CNS and one of the most common causes of sustained neurological disability in young adults. For 20 years, since immunomodulation was introduced for the treatment of relapse activity, interferon beta and glatiramer acetate have been the mainstay of therapy. These treatments are only partly effective, and their effects on the reduction of disability progression are debated. They are administered subcutaneously or intramuscularly, which might affect acceptance and patient adherence. (Source: Lancet Neurology)

Link – 

[Comment] New evidence for teriflunomide in multiple sclerosis

Leave a Comment

More from category

Mothers who breastfeed might have lower multiple sclerosis risk
Mothers who breastfeed might have lower multiple sclerosis risk

(Reuters Health) - Women who breastfeed may have a lower risk of developing multiple sclerosis later in life compared [Read More]

Lipoic acid in nutritional supplements found to help prevent multiple sclerosis, study finds
Lipoic acid in nutritional supplements found to help prevent multiple sclerosis, study finds

(Natural News) The results of a new pilot study showed the efficacy of lipoic acid in the reduction of whole brain [Read More]

Multiple sclerosis symptoms: Immune system problems can trigger PARALYSIS of the legs
Multiple sclerosis symptoms: Immune system problems can trigger PARALYSIS of the legs

MULTIPLE sclerosis - commonly abbreviated to MS - is a type of autoimmune disease which can cause problems with vision, [Read More]

National Patient-Advocacy Organizations Oppose ACA Repeal
National Patient-Advocacy Organizations Oppose ACA Repeal

/About-the-Society/News/National-Patient-Advocacy-Organizations-Oppose-ACA [Read More]

Exclusive: Nurses reluctant to discuss disability with MS patients
Exclusive: Nurses reluctant to discuss disability with MS patients

Nearly two-thirds of specialist nurses are reluctant to discuss disability with patients who have multiple sclerosis, [Read More]